Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase…

Overview of attention for article published in The Lancet Haematology, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 1,291)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 1 public wall post.

干擾素 Alfa-2b 治療低惡性度淋巴瘤樣肉芽腫，可延長存活期根據發表在《刺胳針血液學》(The Lancet Haematology) 期刊的研究顯示，對於低惡性度淋巴瘤樣肉芽腫 (Low-Grade Lymphomatoid…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.